SiRNA screening reveals JNK2 as an evolutionary conserved regulator of triglyceride homeostasis

Journal of Lipid Research

Volumn 49, Issue 11, 2008, Pages 2427-2440

  Grimard, Vinciane ^a   Massier, Julia ^a   Richter, Doris ^a   Schwudke, Dominik ^a   Kalaidzidis, Yannis ^a   Fava, Eugenio ^a   Hermetter, Albin ^b   Thiele, Christoph ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

C jun N terminal kinase; HeLa cells; Kinase; Lipid droplet; Mitogen activated protein kinase 9

Indexed keywords

FAT DROPLET; MITOGEN ACTIVATED PROTEIN KINASE 9; PROTEIN; PROTEIN STY1; SMALL INTERFERING RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE; SCHIZOSACCHAROMYCES POMBE PROTEIN; STY1 PROTEIN, S POMBE;

ARTICLE; CONTROLLED STUDY; EUKARYOTIC CELL; EVOLUTIONARY HOMOLOGY; GENETIC CONSERVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; METABOLIC REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RNA INTERFERENCE; SCHIZOSACCHAROMYCES POMBE; SCREENING; SMALL INTERFERING RNA SCREENING; THIN LAYER CHROMATOGRAPHY; CHEMISTRY; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; HELA CELL; METABOLISM; MOLECULAR EVOLUTION; PHYSIOLOGY; SCHIZOSACCHAROMYCES;

CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; HELA CELLS; HOMEOSTASIS; HUMANS; LIPID METABOLISM; MITOGEN-ACTIVATED PROTEIN KINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SCHIZOSACCHAROMYCES; SCHIZOSACCHAROMYCES POMBE PROTEINS; TRIGLYCERIDES;

EID: 58149473797     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800168-JLR200     Document Type: Article

References (61)

1. Murray, C. J., and A. D. Lopez. 1997. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 349: 1436-1442.
2. Caballero, B. 2005. A nutrition paradox-underweight and obesity in developing countries. N. Engl. J. Med. 352: 1514-1516.
3. Rawson, R. B. 2003. The SREBP pathway-insights from Insigs and insects. Nat. Rev. Mol. Cell Biol. 4: 631-640.
4. Beaven, S. W., and P. Tontonoz. 2006. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu. Rev. Med. 57: 313-329.
5. Zelcer, N., and P. Tontonoz. 2006. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116: 607-614.
6. Kalaany, N. Y., and D. J. Mangelsdorf. 2006. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68: 159-191.
7. Li, A. C., and C. K. Glass. 2004. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J. Lipid Res. 45: 2161-2173.
8. Chawla, A., J. J. Repa, R. M. Evans, and D. J. Mangelsdorf. 2001. Nuclear receptors and lipid physiology: opening the X-files. Science. 294: 1866-1870.
9. Krutzfeldt, J., N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan, and M. Stoffel. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 438: 685-689.
10. Krutzfeldt, J., and M. Stoffel. 2006. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab. 4: 9-12.
11. Xu, P., S. Y. Vernooy, M. Guo, and B. A. Hay. 2003. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr. Biol. 13: 790-795.
12. Esau, C., S. Davis, S. F. Murray, X. X. Yu, S. K. Pandey, M. Pear, L. Watts, S. L. Booten, M. Graham, R. McKay, et al. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3: 87-98.
13. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411: 494-498.
14. Fire, A., S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, and C. C. Mello. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391: 806-811.
15. Carpenter, A. E., and D. M. Sabatini. 2004. Systematic genome-wide screens of gene function. Nat. Rev. Genet. 5: 11-22.
16. Dorsett, Y., and T. Tuschl. 2004. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3: 318-329.
17. Thiele, C., M. J. Hannah, F. Fahrenholz, and W. B. Huttner. 2000. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat. Cell Biol. 2: 42-49.
18. Kuerschner, L., C. S. Ejsing, K. Ekroos, A. Shevchenko, K. I. Anderson, and C. Thiele. 2005. Polyene-lipids: a new tool to image lipids. Nat. Methods. 2: 39-45.
19. Kalaidzidis, Y. L., A. V. Gavrilov, P. V. Zaitsev, A. L. Kalaidzidis, and E. V. Korolev. 1997. PLUK - an environment for software development. Program. Comput. Softw. 23: 206-212.
20. Forsburg, S. L., and N. Rhind. 2006. Basic methods for fission yeast. Yeast. 23: 173-183.
21. Harborth, J., S. M. Elbashir, K. Bechert, T. Tuschl, and K. Weber. 2001. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114: 4557-4565.
22. Weil, D., L. Garcon, M. Harper, D. Dumenil, F. Dautry, and M. Kress. 2002. Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells. Biotechniques. 33: 1244-1248.
23. Harborth, J., S. M. Elbashir, K. Vandenburgh, H. Manninga, S. A. Scaringe, K. Weber, and T. Tuschl. 2003. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13: 83-105.
24. Holen, T., M. Amarzguioui, M. T. Wiiger, E. Babaie, and H. Prydz. 2002. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res. 30: 1757-1766.
25. Kwok, B. H., B. Koh, M. I. Ndubuisi, M. Elofsson, and C. M. Crews. 2001. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem. Biol. 8: 759-766.
26. Jackson, A. L., S. R. Bartz, J. Schelter, S. V. Kobayashi, J. Burchard, M. Mao, B. Li, G. Cavet, and P. S. Linsley. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21: 635-637.
27. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA. 98: 13681-13686.
28. Brown, D. A. 2001. Lipid droplets: proteins floating on a pool of fat. Curr. Biol. 11: R446-R449.
29. Gocze, P. M., and D. A. Freeman. 1994. Factors underlying the variability of lipid droplet fluorescence in MA-10 Leydig tumor cells. Cytometry. 17: 151-158.
30. Schwudke, D., J. T. Hannich, V. Surendranath, V. Grimard, T. Moehring, L. Burton, T. Kurzchalia, and A. Shevchenko. 2007. Top-down lipidomic screens by multivariate analysis of high-resolution survey mass spectra. Anal. Chem. 79: 4083-4093.
31. Oskolkova, O. V., R. Saf, E. Zenzmaier, and A. Hermetter. 2003. Fluorescent organophosphonates as inhibitors of microbial lipases. Chem. Phys. Lipids. 125: 103-114.
32. Degols, G., K. Shiozaki, and P. Russell. 1996. Activation and regulation of the Spc1 stress-activated protein kinase in Schizosaccharomyces pombe. Mol. Cell. Biol. 16: 2870-2877.
33. Stettler, S., E. Warbrick, S. Prochnik, S. Mackie, and P. Fantes. 1996. The wis1 signal transduction pathway is required for expression of cAMP-repressed genes in fission yeast. J. Cell Sci. 109: 1927-1935.
34. Liu, X., A. K. Gupta, P. M. Corry, and Y. J. Lee. 1997. Hypoglycemia-induced c-Jun phosphorylation is mediated by c-Jun N-terminal kinase 1 and Lyn kinase in drug-resistant human breast carcinoma MCF-7/ADR cells. J. Biol. Chem. 272: 11690-11693.
35. Galcheva-Gargova, Z., B. Derijard, I. H. Wu, and R. J. Davis. 1994. An osmosensing signal transduction pathway in mammalian cells. Science. 265: 806-808.
36. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265: 808-811.
37. Greenspan, P., E. P. Mayer, and S. D. Fowler. 1985. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100: 965-973.
38. Tong, F., P. N. Black, L. Bivins, S. Quackenbush, V. Ctrnacta, and C. C. DiRusso. 2006. Direct interaction of Saccharomyces cerevisiae Faa1p with the Omi/HtrA protease orthologue Ynm3p alters lipid homeostasis. Mol. Genet. Genomics. 275: 330-343.
39. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature. 343: 425-430.
40. Song, B. L., N. B. Javitt, and R. A. DeBose-Boyd. 2005. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metab. 1: 179-189.
41. MacKeigan, J. P., L. O. Murphy, and J. Blenis. 2005. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat. Cell Biol. 7: 591-600.
42. Pelkmans, L., E. Fava, H. Grabner, M. Hannus, B. Habermann, E. Krausz, and M. Zerial. 2005. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature. 436: 78-86.
43. Lin, X., X. Ruan, M. G. Anderson, J. A. McDowell, P. E. Kroeger, S. W. Fesik, and Y. Shen. 2005. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res. 33: 4527-4535.
44. Ma, Y., A. Creanga, L. Lum, and P. A. Beachy. 2006. Prevalence of off-target effects in Drosophila RNA interference screens. Nature. 443: 359-363.
45. Birmingham, A., E. M. Anderson, A. Reynolds, D. Ilsley-Tyree, D. Leake, Y. Fedorov, S. Baskerville, E. Maksimova, K. Robinson, J. Karpilow, et al. 2006. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods. 3: 199-204.
46. Doench, J. G., C. P. Petersen, and P. A. Sharp. 2003. siRNAs can function as miRNAs. Genes Dev. 17: 438-442.
47. Lim, L. P., N. C. Lau, P. Garrett-Engele, A. Grimson, J. M. Schelter, J. Castle, D. P. Bartel, P. S. Linsley, and J. M. Johnson. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433: 769-773.
48. Zeng, Y., R. Yi, and B. R. Cullen. 2003. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. USA. 100: 9779-9784.
49. Stark, A., J. Brennecke, N. Bushati, R. B. Russell, and S. M. Cohen. 2005. Animal microRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell. 123: 1133-1146.
50. Jackson, A. L., J. Burchard, J. Schelter, B. N. Chau, M. Cleary, L. Lim, and P. S. Linsley. 2006. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA. 12: 1179-1187.
51. Andersson, L., P. Bostrom, J. Ericson, M. Rutberg, B. Magnusson, D. Marchesan, M. Ruiz, L. Asp, P. Huang, M. A. Frohman, et al. 2006. PLD1 and ERK2 regulate cytosolic lipid droplet formation. J. Cell Sci. 119: 2246-2257.
52. Tuncman, G., J. Hirosumi, G. Solinas, L. Chang, M. Karin, and G. S. Hotamisligil. 2006. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA. 103: 10741-10746.
53. Ricci, R., G. Sumara, I. Sumara, I. Rozenberg, M. Kurrer, A. Akhmedov, M. Hersberger, U. Eriksson, F. R. Eberli, B. Becher, et al. 2004. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science. 306: 1558-1561.
54. Hirosumi, J., G. Tuncman, L. Chang, C. Z. Gorgun, K. T. Uysal, K. Maeda, M. Karin, and G. S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature. 420: 333-336.
55. Nishio, H., K. Matsui, H. Tsuji, A. Tamura, and K. Suzuki. 2001. Immunohistochemical study of the phosphorylated and activated form of c-Jun NH2-terminal kinase in human aorta. Histochem. J. 33: 167-171.
56. Chen, D., W. M. Toone, J. Mata, R. Lyne, G. Burns, K. Kivinen, A. Brazma, N. Jones, and J. Bahler. 2003. Global transcriptional responses of fission yeast to environmental stress. Mol. Biol. Cell. 14: 214-229.
57. Ryden, M., E. Arvidsson, L. Blomqvist, L. Perbeck, A. Dicker, and P. Arner. 2004. Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem. Biophys. Res. Commun. 318: 168-175.
58. Souza, S. C., L. M. de Vargas, M. T. Yamamoto, P. Lien, M. D. Franciosa, L. G. Moss, and A. S. Greenberg. 1998. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 273: 24665-24669.
59. Manning, A. M., and R. J. Davis. 2003. Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. 2: 554-565.
60. Karin, M., and E. Gallagher. 2005. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life. 57: 283-295.
61. Sumara, G., M. Belwal, and R. Ricci. 2005. "Jnking" atherosclerosis. Cell. Mol. Life Sci. 62: 2487-2494.